ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RCKT Rocket Pharmaceuticals Inc

29.79
0.00 (0.00%)
Pre Market
Last Updated: 07:59:28
Delayed by 15 minutes

Period:

Draw Mode:

Volume 22
Bid Price 29.79
Ask Price 32.50
News -
Day High

Low
14.89

52 Week Range

High
32.525

Day Low
Company Name Stock Ticker Symbol Market Type
Rocket Pharmaceuticals Inc RCKT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 29.79 07:59:28
Open Price Low Price High Price Close Price Prev Close
29.79
Trades Volume Avg Volume 52 Week Range
4 22 - 14.89 - 32.525
Last Trade Time Type Quantity Stock Price Currency
08:02:59 1 $ 30.52 USD

Rocket Pharmaceuticals (RCKT) Options Flow Summary

Overall Flow

Bullish

Net Premium

67k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Rocket Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.69B 90.16M - 0 -221.86M -2.46 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Rocket Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RCKT Message Board. Create One! See More Posts on RCKT Message Board See More Message Board Posts

Historical RCKT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week29.5030.439928.1029.04736,3100.290.98%
1 Month28.9230.8026.9929.15720,1280.873.01%
3 Months24.5232.52524.3028.39837,3185.2721.49%
6 Months15.9832.52515.2723.331,074,90513.8186.42%
1 Year18.4032.52514.8921.62903,66811.3961.90%
3 Years56.3058.727.56522.04731,221-26.51-47.09%
5 Years16.8567.487.56523.18581,57812.9476.80%

Rocket Pharmaceuticals Description

Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Your Recent History

Delayed Upgrade Clock